Management of COVID-19 patients with chronic liver diseases and liver transplants

The epidemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has increasingly attracted worldwide concern. Liver damage or dysfunction occurred in patients with COVID-19 (mainly characterized by moderately elevated serum aspartate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xinyu, Sun, Longyan, Guo, Zhaoyang, Wu, Chao, Yu, Xin, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2022
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683212/
https://www.ncbi.nlm.nih.gov/pubmed/34929350
http://dx.doi.org/10.1016/j.aohep.2021.100653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683212/
https://www.ncbi.nlm.nih.gov/pubmed/34929350
http://dx.doi.org/10.1016/j.aohep.2021.100653

Ejemplares similares